respiratory syncytial virus

Lipid blocks influenza infection

EurekAlert! - Infectious and Emerging Diseases  Tue, 11/08/2011 - 23:00

(National Jewish Health) A natural lipid in the fluid lining the lungs inhibits influenza infections in both cell cultures and mouse models, according to researchers at National Jewish Health.

These findings, combined with previous studies demonstrating effectiveness against respiratory syncytial virus, suggest that the molecule, known as POPG, may have broad antiviral activity.

Supplemental POPG could be an important, inexpensive and novel approach for the prevention and treatment of influenza and other respiratory virus infections.


 

Low Vitamin D at Birth Linked to Lung Infections

WebMD Health  Tue, 05/10/2011 - 15:25

newborn baby and the letter d

Newborns with low vitamin D levels have a sixfold higher risk of lung infections with respiratory syncytial virus (RSV), Dutch researchers report.


 

Biologic Is Bad Buy for RSV Prevention (CME/CE)

MedPage Today Infectious Disease  Thu, 02/10/2011 - 07:45

(MedPage Today) -- Preventing respiratory syncytial virus (RSV) infections in infants and toddlers with palivizumab (Synagis) costs far more than treating hospitalizations when they occur, researchers said.


 

Severe RSV in First Year Linked to Later Wheezing (CME/CE)

MedPage Today Infectious Disease  Tue, 10/05/2010 - 07:00

(MedPage Today) -- Severe respiratory syncytial virus infection during the first year of life is associated with the development of recurrent wheezing, a retrospective cohort study found.


 

RSV Burden Higher than Thought in Kids Up to Five

MedPage Today Infectious Disease  Wed, 02/04/2009 - 15:00

ROCHESTER, N.Y. (MedPage Today) -- The burden of respiratory syncytial virus in children as old as five is far higher than had been recognized, researchers here said.


 

PAS: Motavizumab Cuts RSV Infection and Hospitalization Rates

MedPage Today Infectious Disease  Mon, 05/05/2008 - 11:24

HONOLULU -- Motavizumab, a humanized monoclonal antibody to respiratory syncytial virus (RSV) reduced hospital admissions among American-Indian infants by 83% compared with placebo, in a phase III study, researchers reported here.